Acquisitions & Agreements
Acquisitions & Agreements
• Bacompt Systems (Carmel, IN) and Silanis Tech nology (Montreal) have formed an alliance to provide companies in industries regulated by the Food and Drug Administration with a web product for the approval and management of clinical documents. The new system will incorporate Silanis’ ApproveIt electronic approval software with Bacompt’s Clinical Asset Management System. The resulting product is expected to allow businesses to collaborate, retrieve, management, distribute, and approve electronic documents around the world.
• Computer Sciences (El Segundo, CA) has formed a partnership with Symmetry Health Data Systems (Palo Alto, CA) to use Symmetry’s Episode Treatment Groups (ETGs) to improve its data management applications. The ETG system will complement Computer Sciences use of Johns Hopkins’ Adjusted Clinical Groups to boost its total risk adjustment package. ETG is an illness classification, episode-building methodology using routinely collected inpatient data and ambulatory claims data.
• Gene Logic (Columbia, MD) will use Affymetrix’s (Santa Clara, CA) GeneChip probe arrays to build large, commercial gene expression database products. Gene Logic will receive annual subscription fees from database users. The databases will be marketed to pharmaceutical and biotechnology companies.
• HCIA (Baltimore) has won a two-year contract to create a data warehouse for the California Workers’ Comp en sation Institute (San Francisco). Financial terms were not disclosed. HCIA will provide web-based analytic tools to study costs, outcomes, and management of workers’ compensation plans in California. HCIA and the institute will explore the market potential for HCIA’s physician profiling and fraud and abuse tools.
• Healthdyne Information Enterprises (HIE; Marietta, GA) has signed National Computer Systems (NCS) as the HIE Cloverleaf business partner for Singapore. NCS will provide maintenance and help desk support for HIE’s Cloverleaf message broker to seven Singapore hospitals. NCS is a subsidiary of the Singapore Telecom Group.
• Incyte Pharmaceuticals (Palo Alto, CA) and Pharmacia & Upjohn (Bridgewater, NJ ) have expanded their genomic database agreement. The multiyear agreement will give Pharmacia & Upjohn access to Incyte’s PathoSeq microbial database to use in its infectious disease programs. Incyte will receive annual access fees and could receive royalties on sales of products developed with Incyte technology and database information. Financial terms were not disclosed.
• ISG Technologies (Mississauga, Ontario) has signed an agreement to supply its ISG VR SoftSTore image management and archive software to META Solutions (Linthicum, MD). META will integrate VR SoftSTore software into its distributed image management offering. The ISG product is used in picture archiving and communications systems to store and manage the access and movement of diagnostic images through a healthcare system.
• McKesson (San Francisco) has entered into an agreement to acquire Kelly/Waldron and Kelly Waldron/ SFA. Kelly/Waldron provides sales, data analysis and marketing information services to the pharmaceutical industry. Kelly Waldron/SFA provides sales force automation systems and services for pharmaceutical sales forces.
• Pangea Systems (Oakland, CA) has licensed its computational tools to Genetics Institute (GI; Cambridge, MA) for use in GI’s genomics program. The tools will more rapid and accurate clustering and alignment of expressed sequence tags and full length genetic sequences, as well as the ability to integrate data from public and proprietary databases.
• ProxyMed (Fort Lauderdale, FL) has purchased Key Communications Service (New Albany, IN), a privately held information hardware and software maker, for $21.9 million. ProxyMed paid two million shares of its stock for Key Communications, which makes products that allow laboratory results to be delivered electronically. The deal gives ProxyMed access to Key’s customer base of more than 1,800 clinical laboratories.
Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.